Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
It is part of the company’s pain/analgesics portfolio of OTC products
Five seats reserved for Wards of COVID warriors in central MBBS admission
It is designed to tackle mental health issues
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
Complementary business models are the reason for the acquisition
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Subscribe To Our Newsletter & Stay Updated
